| 摘要 |
Compounds according to formulas (I), (II), (III) and (IV), the residues R1 to R4 being defined in the description, can be used in the form of usual galenic preparations to prevent cytotoxic effects, for example of damages due to ischemia, and for cardioprotection.
|
| 申请人 |
BOEHRINGER INGELHEIM KG, 6507 INGELHEIM, DE |
发明人 |
ENSINGER, HELMUT, DIPL.-CHEM. DR.;BIRKE, FRANZ, DIPL.-BIO-CHEM. DR., 6507 INGELHEIM, DE;STRELLER, ILSE, DR., 6534 STROMBERG, DE;SCHROMM, KURT, DIPL.-CHEM. DR., 6507 INGELHEIM, DE |
